Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q2623398> ?p ?o }
Showing triples 1 to 70 of
70
with 100 triples per page.
- Q2623398 subject Q6442932.
- Q2623398 subject Q7428637.
- Q2623398 subject Q7482068.
- Q2623398 subject Q8236082.
- Q2623398 subject Q8256025.
- Q2623398 subject Q8421354.
- Q2623398 abstract "Nicergoline (INN, marketed under the trade name Sermion) is an ergot derivative used to treat senile dementia and other disorders with vascular origins. It has been found to increase mental agility and enhance clarity and perception. It decreases vascular resistance and increases arterial blood flow in the brain, improving the utilization of oxygen and glucose by brain cells. It has similar vasoactive properties in other areas of the body, particularly the lungs.It is used for vascular disorders such as cerebral thrombosis and atherosclerosis, arterial blockages in the limbs, Raynaud's disease, vascular migraines, and retinopathy.Nicergoline has been registered in over fifty countries and has been used for more than three decades for the treatment of cognitive, affective, and behavioral disorders of older people.".
- Q2623398 atcPrefix "C04".
- Q2623398 atcSuffix "AE02".
- Q2623398 casNumber "27848-84-6".
- Q2623398 drugbank "DB00699".
- Q2623398 fdaUniiCode "JCV8365FWN".
- Q2623398 iupacName "[(8β)-10-methoxy-1,6-dimethylergolin-8-yl]methyl 5-bromopyridine-3-carboxylate".
- Q2623398 pubchem "34040".
- Q2623398 thumbnail Nicergoline_Structure_V.1.svg?width=300.
- Q2623398 wikiPageExternalLink news_detail_001832.jsp&mid=WC0b01ac058004d5c1b).
- Q2623398 wikiPageExternalLink 496556.
- Q2623398 wikiPageWikiLink Q101026.
- Q2623398 wikiPageWikiLink Q12133.
- Q2623398 wikiPageWikiLink Q12152.
- Q2623398 wikiPageWikiLink Q12252367.
- Q2623398 wikiPageWikiLink Q1330121.
- Q2623398 wikiPageWikiLink Q133823.
- Q2623398 wikiPageWikiLink Q1424106.
- Q2623398 wikiPageWikiLink Q14859627.
- Q2623398 wikiPageWikiLink Q14873931.
- Q2623398 wikiPageWikiLink Q1588755.
- Q2623398 wikiPageWikiLink Q17710494.
- Q2623398 wikiPageWikiLink Q217111.
- Q2623398 wikiPageWikiLink Q261327.
- Q2623398 wikiPageWikiLink Q271759.
- Q2623398 wikiPageWikiLink Q275466.
- Q2623398 wikiPageWikiLink Q413581.
- Q2623398 wikiPageWikiLink Q420288.
- Q2623398 wikiPageWikiLink Q423364.
- Q2623398 wikiPageWikiLink Q432083.
- Q2623398 wikiPageWikiLink Q43284.
- Q2623398 wikiPageWikiLink Q4362563.
- Q2623398 wikiPageWikiLink Q456026.
- Q2623398 wikiPageWikiLink Q5142470.
- Q2623398 wikiPageWikiLink Q550455.
- Q2623398 wikiPageWikiLink Q5814478.
- Q2623398 wikiPageWikiLink Q631521.
- Q2623398 wikiPageWikiLink Q640448.
- Q2623398 wikiPageWikiLink Q6442932.
- Q2623398 wikiPageWikiLink Q6445454.
- Q2623398 wikiPageWikiLink Q7428637.
- Q2623398 wikiPageWikiLink Q7482068.
- Q2623398 wikiPageWikiLink Q8236082.
- Q2623398 wikiPageWikiLink Q824258.
- Q2623398 wikiPageWikiLink Q8256025.
- Q2623398 wikiPageWikiLink Q83030.
- Q2623398 wikiPageWikiLink Q830308.
- Q2623398 wikiPageWikiLink Q8421354.
- Q2623398 wikiPageWikiLink Q988343.
- Q2623398 atcPrefix "4.0".
- Q2623398 atcSuffix "AE02".
- Q2623398 casNumber "27848".
- Q2623398 drugbank "DB00699".
- Q2623398 iupacName "[-10-methoxy-1,6-dimethylergolin-8-yl]methyl 5-bromopyridine-3-carboxylate".
- Q2623398 pubchem "34040".
- Q2623398 unii "JCV8365FWN".
- Q2623398 type ChemicalSubstance.
- Q2623398 type Drug.
- Q2623398 type ChemicalObject.
- Q2623398 type Thing.
- Q2623398 type Q8386.
- Q2623398 comment "Nicergoline (INN, marketed under the trade name Sermion) is an ergot derivative used to treat senile dementia and other disorders with vascular origins. It has been found to increase mental agility and enhance clarity and perception. It decreases vascular resistance and increases arterial blood flow in the brain, improving the utilization of oxygen and glucose by brain cells.".
- Q2623398 label "Nicergoline".
- Q2623398 depiction Nicergoline_Structure_V.1.svg.